Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. With funding from the National ...

Even as they have revolutionized the treatment of certain forms of cancer, CAR T-cell therapies have been shadowed by a significant limitation: many patients, including those whose cancer goes into ...

Researchers introduce a chimeric antigen receptor–enhancer (CAR-E) therapeutic platform that significantly extends the effectiveness and memory of CAR T cells, potentially preventing relapse in ...

(WISH) — Chimeric antigen receptor T-cell therapy is revolutionizing the treatment of certain blood cancers. CAR T-cell therapy uses genetically enhanced versions of a patient’s own cancer-fighting ...

CHICAGO — Tocilizumab (TCZ) appears to be more effective than methotrexate (MTX) for giant cell arteritis (GCA) in maintaining remission and preventing relapse at 52 weeks, according to new data from ...